3-Hexanone, 5-mercapto-5-methyl-
Common Name: |
3-Hexanone, 5-mercapto-5-methyl- |
IUPAC Name: |
5-methyl-5-sulfanylhexan-3-one |
Molecular Formula: |
C12H16O |
SMILES: |
CCC(=O)CC(C)(C)S |
Inchi: |
1S/C7H14OS/c1-4-6(8)5-7(2,3)9/h9H,4-5H2,1-3H3 |
Inchi Key: |
KTTLFUWDFUJAKG-UHFFFAOYSA-N |
Cas No: |
851768-51-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
176.25 |
Mass (g/mol) |
146.077 |
Molar Refractivity |
54.55 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
198.78 |
Vapor Pressure (mmHg@25.00 °C) |
0.353 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.064 |
iLOGP |
2.36 |
XLOGP3 |
2.55 |
WLOGP |
2.09 |
MLOGP |
2.67 |
ESOL Log S |
-2.81 |
ESOL Solubility (mg/ml) |
0.27 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.62 |
Ali Solubility (mg/ml) |
0.42 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.82 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.56 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.352 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.861 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |